Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Visus Therapeutics
Biotech
2 eye disease biotechs merge, set sights on FDA approval
London-based Tenpoint and Seattle-based Visus have merged, tapping Henric Bjarke to helm the new entity.
Gabrielle Masson
Dec 12, 2024 11:05am
Visus, with one drug chasing AbbVie, inks deals to grow pipeline
Aug 19, 2021 8:35am
Visus raises $20M ahead of data drop on rival to AbbVie prospect
Aug 10, 2021 9:10am
